132 related articles for article (PubMed ID: 3678328)
21. Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
Saiki JH; Baker LH; Stephens RL; Fabian CJ; Kraut EH; Fletcher WS
Cancer Treat Rep; 1982 Aug; 66(8):1673-4. PubMed ID: 7105060
[No Abstract] [Full Text] [Related]
22. Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.
Gounder MM; Zer A; Tap WD; Salah S; Dickson MA; Gupta AA; Keohan ML; Loong HH; D'Angelo SP; Baker S; Condy M; Nyquist-Schultz K; Tanner L; Erinjeri JP; Jasmine FH; Friedlander S; Carlson R; Unger TJ; Saint-Martin JR; Rashal T; Ellis J; Kauffman M; Shacham S; Schwartz GK; Abdul Razak AR
J Clin Oncol; 2016 Sep; 34(26):3166-74. PubMed ID: 27458288
[TBL] [Abstract][Full Text] [Related]
23. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
[No Abstract] [Full Text] [Related]
24. Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomas.
Vosika GJ; Briscoe K; Carey RW; O'Donnell JF; Perry MC; Budman D; Richards F; Coleman M
Cancer Treat Rep; 1981; 65(9-10):823-5. PubMed ID: 7273013
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study.
Verweij J; Krzemieniecki K; Kok T; Poveda A; van Pottelsberghe C; van Glabbeke M; Mouridsen H
Eur J Cancer; 1993; 29A(2):208-9. PubMed ID: 8422284
[TBL] [Abstract][Full Text] [Related]
26. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
[No Abstract] [Full Text] [Related]
27. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
Judson I; Radford JA; Harris M; Blay JY; van Hoesel Q; le Cesne A; van Oosterom AT; Clemons MJ; Kamby C; Hermans C; Whittaker J; Donato di Paola E; Verweij J; Nielsen S
Eur J Cancer; 2001 May; 37(7):870-7. PubMed ID: 11313175
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of merbarone in soft tissue sarcoma. A Southwest Oncology Group study.
Kraut EH; Bendetti J; Balcerzak SP; Doroshow JH
Invest New Drugs; 1992 Nov; 10(4):347-9. PubMed ID: 1487411
[TBL] [Abstract][Full Text] [Related]
29. Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.
Buesa JM; Mouridsen HT; Santoro A; Somers R; Bramwell V; van Oosterom AT; Wagener T; Vendrik C; Thomas D
Cancer Treat Rep; 1984 Apr; 68(4):683-4. PubMed ID: 6713423
[No Abstract] [Full Text] [Related]
30. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
[No Abstract] [Full Text] [Related]
31. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.
Steward WP; Verweij J; Somers R; Blackledge G; Clavel M; Van Oosterom AT; Greifenberg B; Soedirman J; Thomas D; Van Glabbeke M
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S193-7. PubMed ID: 1795008
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
[No Abstract] [Full Text] [Related]
33. Phase I clinical study of carminomycin: its activity against soft tissue sarcomas.
Perevodchikova NI; Lichinitser MR; Gorbunova VA
Cancer Treat Rep; 1977 Dec; 61(9):1705-7. PubMed ID: 340034
[No Abstract] [Full Text] [Related]
34. N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group.
Bramwell V; Van Oosterom A; Mouridsen HT; Cheix F; Somers R; Thomas D; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):81-4. PubMed ID: 6211362
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy for advanced soft-tissue sarcomas: results of phase I and II cooperative studies.
Mitts DL; Gerhardt H; Armstrong D; Aust JB; Cruz AB
Tex Med; 1979 May; 75(5):43-7. PubMed ID: 377553
[No Abstract] [Full Text] [Related]
36. The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer.
Donato Di Paola E; Nielsen OS;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S138-41. PubMed ID: 11858980
[TBL] [Abstract][Full Text] [Related]
37. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
[TBL] [Abstract][Full Text] [Related]
38. Fludarabine phosphate. Phase II evaluation in advanced soft-tissue sarcomas.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Aug; 10(4):341-3. PubMed ID: 2441592
[TBL] [Abstract][Full Text] [Related]
39. Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).
Schmitt T; Mayer-Steinacker R; Mayer F; Grünwald V; Schütte J; Hartmann JT; Kasper B; Hüsing J; Hajda J; Ottawa G; Mechtersheimer G; Mikus G; Burhenne J; Lehmann L; Heilig CE; Ho AD; Egerer G
Eur J Cancer; 2016 Sep; 64():74-82. PubMed ID: 27367154
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma.
Licht JD; Gonin R; Antman KH
Cancer Chemother Pharmacol; 1991; 28(3):223-5. PubMed ID: 1830249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
